Back to search

Article

Sex Representation in U.S. Clinical Trials: A Statistical Benchmarking Study

2025-05-23

Abstract excerpt

<title>Abstract</title> <p>Background Sex equity in clinical research is essential for generalizable and safe medical care. Historical underrepresentation of women in trials has prompted decades of policy reform. Whether these reforms have succeeded remains inadequately assessed with statistical rigor. Methods We analyzed 1,825 U.S.-based clinical trials registered between 2000 and 2024 using ClinicalTrials.gov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
769f839c-fb91-56a3-b0f5-2ae430122c72
DOI
10.21203/rs.3.rs-6702437/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sex Representation in U.S. Clinical Trials: A Statistical Benchmarking StudyDOI 10.21203/rs.3.rs-6702437/v1
Lack of precision in the reporting of sex and gender in cancer clinical trials with a PRO endpoint: a systematic reviewSemantic proximity
The Sparse Matrix of Drug Discovery: Sex, Race, and a Genomic Equity Index Across 40.8 Million Patients in 77,770 Clinical TrialsSemantic proximity
Reporting of socio-demographic characteristics of trial participants in infectious diseases clinical trials – a systematic reviewSemantic proximity
New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA Approved Drugs and BiologicsSemantic proximity
The Current Landscape of Clinical TrialsSemantic proximity
Mapping equity, diversity, and inclusion in pivotal device clinical investigations: A scoping review protocolSemantic proximity
Current State and Demographic Trends of Medically Underserved Populations in Rare Disease Research in the United StatesSemantic proximity
The Dearth of Representation in FDA Approved Drug TrialsSemantic proximity
A Framework for Inclusive and Accessible Clinical Research in Rare DiseasesSemantic proximity
Demographic Representation of a Decentralized Long COVID Trial: A Comparison with the 2023 National Health Interview SurveySemantic proximity
Sociodemographic Bias in Large Language Model Clinical Trial ScreeningSemantic proximity
Racial and Ethnic Diversity in Clinical Studies Reported to ClinicalTrials.gov, 2009-2024Semantic proximity
Select a neighboring publication to make it the new centre.